Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04938167 · ClinicalTrials.gov registry record · NA
Preductal Oxygen Saturation Target in Term and Late Preterm Neonates With Hypoxemic Respiratory Failure or Pulmonary Hypertension
A NA study of Persistent Pulmonary Hypertension of the Newborn and Hypoxemic Respiratory Failure, sponsored by University of California, Davis.
- Active
- Registry status
- NA
- Development phase
- 54
- Enrollment target
- 1
- Study location
NCT04938167: Active NA study of Persistent Pulmonary Hypertension of the Newborn and Hypoxemic Respiratory Failure, sponsored by University of California, Davis.
NCT04938167 is a NA study of Persistent Pulmonary Hypertension of the Newborn and Hypoxemic Respiratory Failure that is active but no longer recruiting, run by University of California, Davis. The registered enrollment target is 54 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04938167, a NA study of Persistent Pulmonary Hypertension of the Newborn and Hypoxemic Respiratory Failure, is active but no longer recruiting, sponsored by University of California, Davis.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 54 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research is to evaluate two oxygen saturation goals for newborns with pulmonary hypertension. Participation in this research will involve random assignment to one of two oxygen saturation goals, review of the medical record and targeted echocardiograms.
Primary Outcome
Most randomized trials evaluating PPHN have taken oxygenation, echocardiographic evidence of PH or survival with extracorporeal membrane oxygenation (ECMO) as primary endpoints. Oxygenation was primarily assessed with postductal arterial gases. More recently, preductal SpO2 and blood gases have been shown to have advantages during management of PPHN with congenital diaphragmatic hernia (CDH). Given the low need for ECMO in PPHN (other than due to CDH), the investigators have developed a HRF/PH s
Conditions Studied
Interventions
- OTHER 95% - 99% SpO2 target
Study Locations (1)
California
- University of California-Davis - Sacramento
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2021-08-01 |
| Est. Completion | 2025-12-31 |
| Phase | NA |
What the registry record for NCT04938167 still lists
NCT04938167 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 54 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 2 conditions, with Persistent Pulmonary Hypertension of the Newborn appearing as the primary indexed condition, and to 1 intervention - of which 95% - 99% SpO2 target is the first listed.
NCT04938167 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT04938167 about?
NCT04938167 is a clinical study titled "Preductal Oxygen Saturation Target in Term and Late Preterm Neonates With Hypoxemic Respiratory Failure or Pulmonary Hypertension". The purpose of this research is to evaluate two oxygen saturation goals for newborns with pulmonary hypertension. Participation in this research will involve random assignment to one of two oxygen saturation goals, review of the medical record and targeted echocardiograms.
What is the current status of trial NCT04938167?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 54 participants. The study started on 2021-08-01. Estimated completion is 2025-12-31.
What conditions does trial NCT04938167 study?
This clinical trial studies the following conditions: Persistent Pulmonary Hypertension of the Newborn, Hypoxemic Respiratory Failure.
What interventions are being tested in trial NCT04938167?
The interventions under investigation include: 95% - 99% SpO2 target (OTHER).
Who is sponsoring clinical trial NCT04938167?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04938167 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Persistent Pulmonary Hypertension of the Newborn
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04938167's enrollment target sits among peer trials
54 1268th of 2000 higher than 730 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01269853 · 54 participants · Phase 1
Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA
- NCT02390752 · 54 participants · Phase 1
Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...
- NCT02991248 · 54 participants · NA
Improve Dynamic Lateral Balance of Humans With SCI
- NCT02993900 · 54 participants · NA
Image-Guided Gynecologic Brachytherapy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI